Abstract
Case Report Case Report
A 47-year-old obese male with hypertension, anxiety, depression, alcohol abuse, and a 36-year history of tobacco use presented with gross hematuria. He had no reported history suggestive of any familial RCC syndromes. Computerized tomography scan ( fig. 1 ) revealed a 10 × 7.3 cm enhancing infiltrative tumor in the upper pole of the right kidney with a tumor thrombus extending into the IVC below the liver (level I). A concomitant 5 × 4.5 cm enhancing infiltrative tumor in the left kidney with tumor thrombus into the left renal vein and a 2 × 1.4 cm left adrenal nodule concerning for metastasis were present. Bilateral multiple smaller renal masses were also present.
The patient underwent open bilateral radical nephrectomy with IVC tumor thrombectomy and left renal vein tumor thrombectomy. He was started on hemodialysis on postoperative day 1 and did not have any significant postoperative complications. His pathology revealed bilateral clear cell RCC, Fuhrman grade 3, with metastasis to the left adrenal gland; pT3b N0M0 and pT3a N0M1 on the right and left, respectively. This pattern of tumor spread highlights the rare, heterogeneous, and aggressive behavior of clear cell RCC.
Discussion
RCC constitutes 2-3% of all cancers in the United States, with approximately 65,000 new cases and 13,000 deaths due to RCC occurring in the country each year Lin/Watts/Davuluri/Aboumohamed disease have different intrinsic biological behavior compared to sporadic, non-familial bilateral RCC, with the former tending to occur in a multifocal manner and at a younger age [4] . Presentation similar to our case with young age and no family history of renal cancer or RCC familial syndromes is exceptionally rare. Additionally, just 4-10% of RCCs involve tumor thrombus extension into the renal vein and IVC [2] . To our knowledge, no published reports of concomitant bilateral thrombus extension (clinical stage T3a+) exists in the literature, thus making our case a unique presentation of the disease.
Surgery is the treatment of choice for sporadic bilateral RCCs as it has been shown to progress similarly to unilateral RCC and may have a similar prognosis [5] . Patients with bilateral RCCs without tumor thrombus often undergo nephron-sparing surgery given the importance of renal preservation, and particularly the association between chronic kidney disease and risk of cardiovascular events and death [5] . Surgeons must balance the need for complete eradication of malignant tissue with maintenance of renal function [4] . Options include radical nephrectomy of the kidney bearing large or multiple tumors followed by partial nephrectomy of the contralateral kidney harboring a smaller tumor burden, or bilateral partial nephrectomies for bilateral small tumors [4] . The surgery can be done in either a single setting or a staged setting. Small cohort studies have not shown a significant difference in tumor recurrence, postoperative complications, or length-of-stay when comparing single versus staged procedures. Therefore, tumor removal may be safely done in a single surgery, decreasing the risk associated with a second procedure [6] .
For RCCs with tumor thrombus extension (clinical stage cT3a or higher), treatment typically involves radical nephrectomy and tumor thrombectomy. Median survival for patients who do not receive treatment is only 5 months; the 5-year survival rate for those who undergo incomplete tumor resection is approximately 10% [7, 8] . However, complete surgical resection results in a 5-year survival rate of up to 60% in some series [7] . An open approach has traditionally been favored, although minimally-invasive approaches using both hand-or robot-assisted laparoscopic techniques have been increasingly very selectively utilized [9] . Due to the fact that our patient had large bilateral RCCs with tumor thrombi extending into the renal vein and IVC on the left and right sides, respectively, nephron sparing was not feasible and he required a bilateral radical nephrectomy with tumor thrombectomy. He remains without evidence of recurrence at present. 
